Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A V Boddy

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Epilepsy Research|June 1, 1992
Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentolD D Shen, R H Levy, J L Savitch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacokinetics and metabolism of cyclophosphamide in paediatric patientsM J Tasso, A V Boddy, L Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patientsB Peng, A V Boddy, M Cole, et al.
Pharmaceutical Research|June 1, 1991
In vitro and in vivo investigations of dihydropyridine-based chemical delivery systems for anticonvulsantsA V Boddy, K Zhang, F Lepage, et al.
British Journal of Cancer|September 11, 2008
Estimation of renal function and its potential impact on carboplatin dosing in children with cancerG Chinnaswamy, M Cole, A V Boddy, et al.
British Journal of Cancer|May 9, 2007
Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivoJ L Armstrong, G A Taylor, H D Thomas, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in childrenA Patoux, N Bleyzac, A V Boddy, et al.
British Journal of Cancer|January 1, 1997
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapyB Peng, M J Tilby, M W English, et al.
British Journal of Cancer|January 8, 2004
Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokineticsM Cole, L Price, A Parry, et al.
British Journal of Cancer|January 1, 1997
A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancerN Siddiqui, A V Boddy, H D Thomas, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Epilepsy Research|June 1, 1992
Comparative anticonvulsant potency and pharmacokinetics of (+)-and (-)-enantiomers of stiripentolD D Shen, R H Levy, J L Savitch, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
Pharmacokinetics and metabolism of cyclophosphamide in paediatric patientsM J Tasso, A V Boddy, L Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1995
Comparison of methods for the estimation of carboplatin pharmacokinetics in paediatric cancer patientsB Peng, A V Boddy, M Cole, et al.
Pharmaceutical Research|June 1, 1991
In vitro and in vivo investigations of dihydropyridine-based chemical delivery systems for anticonvulsantsA V Boddy, K Zhang, F Lepage, et al.
British Journal of Cancer|September 11, 2008
Estimation of renal function and its potential impact on carboplatin dosing in children with cancerG Chinnaswamy, M Cole, A V Boddy, et al.
British Journal of Cancer|May 9, 2007
Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivoJ L Armstrong, G A Taylor, H D Thomas, et al.
European Journal of Clinical Pharmacology|September 11, 2001
Comparison of nonlinear mixed-effect and non-parametric expectation maximisation modelling for Bayesian estimation of carboplatin clearance in childrenA Patoux, N Bleyzac, A V Boddy, et al.
British Journal of Cancer|January 1, 1997
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapyB Peng, M J Tilby, M W English, et al.
British Journal of Cancer|January 8, 2004
Estimation of glomerular filtration rate in paediatric cancer patients using 51CR-EDTA population pharmacokineticsM Cole, L Price, A Parry, et al.
British Journal of Cancer|January 1, 1997
A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancerN Siddiqui, A V Boddy, H D Thomas, et al.
Pageof 8